PolarityTE, Inc. – Trademark Portfolio
Entity Type: 03
PolarityTE, Inc. holds 33 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 21 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include IBEX, SKINTE, POLARITYTE, and WHERE SELF REGENERATES SELF. The owner is based in Salt Lake City, UT.
123 N. Wright Brothers Drive
Salt Lake City, UT 84116
Showing of trademarks Trademarks
Trademark Classifications
PolarityTE, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does PolarityTE, Inc. have?
PolarityTE, Inc. has 33 U.S. trademarks filed with the USPTO. Of these, 7 registered, 25 abandoned, 1 cancelled.
What trademark classes does PolarityTE, Inc. file in?
PolarityTE, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PolarityTE, Inc.'s most well-known trademarks?
PolarityTE, Inc.'s registered trademark portfolio includes well-known marks such as IBEX, SKINTE, POLARITYTE, and WHERE SELF REGENERATES SELF. These are among 7 currently registered trademarks in the portfolio.
What is PolarityTE, Inc.'s trademark registration success rate?
PolarityTE, Inc. has a 21% trademark registration rate, with 7 out of 33 resolved applications resulting in successful registration. Currently, 0 applications are pending review.